Align Technology logo

ALGN

NASDAQ

Align Technology

Price unavailable — configure POLYGON_API_KEY

Key Statisticslimited data
Market Cap$13.56B
P/E RatioN/A
Div. Yield
EPS (TTM)$5.82
52W High
52W Low
SectorHealth Care
Industry
Employees20,290
Price Performance
1 Week+2.54%
3 Month+6.54%
1 Year+10.61%
FinancialsAnnual · QuiverQuant
Revenue$3.86B
Assets$6.08B
Liabilities$2.45B
Net Income$445.05M

About

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

WebullFree stocks

Advanced charting, extended hours trading, and free stock for new accounts.

Open Account
Analyze ALGN with professional charts— Free to start

Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.